Photo Rounds

Rash, diarrhea, and eosinophilia

Author and Disclosure Information

 

References

Dx: Strongyloides stercoralis hyperinfection syndrome

We suspected a parasitic infection because our patient was a refugee with pulmonary, gastrointestinal (GI), and skin complaints, as well as intermittent eosinophilia. Her negative O&P test upon arrival to the United States did not, however, eliminate the possibility of Strongyloides stercoralis, which often goes undetected in routine O&P samples. A serum test for Strongyloides immunoglobulin G (IgG) was positive at 6.39 IV (positive, >2.11 IV). Subsequently, multiple stool samples were tested specifically for the parasite and came back positive, confirming the diagnosis.

Strongyloidiasis is caused by the roundworm S. stercoralis (FIGURE 3), which infects approximately 30 to 100 million people worldwide.1 It is most common in warm, humid climates in subtropical and tropical regions. With increasing trends in migration and travel, strongyloidiasis is now often diagnosed in nonendemic areas.2

The disease is most prevalent in socioeconomically disadvantaged communities and in agricultural settings. Infection in humans occurs when bare skin comes into contact with contaminated soil. The human T-cell lymphotropic virus-1 (HTLV-1) also predisposes individuals to developing strongyloidiasis.1

Pages

Recommended Reading

High death rates for IBD patients who underwent emergency resections
MDedge Family Medicine
Shorter colonoscopies tied to higher colorectal cancer rates
MDedge Family Medicine
Sofosbuvir-velpatasvir combo effective in all HCV genotypes
MDedge Family Medicine
ICAAC: GI PCR test helped infection control in a children’s hospital
MDedge Family Medicine
Readmissions for C. difficile infections high among elderly
MDedge Family Medicine
Sitting time linked to NAFLD
MDedge Family Medicine
ICAAC: Synergistic effects of two pediatric vaccines highlighted
MDedge Family Medicine
ECC: Nivolumab, Cabozantinib bring long overdue options to advanced kidney cancer
MDedge Family Medicine
ESC: New support for aspirin’s anticancer effect
MDedge Family Medicine
PCORI approves $83 million for HCV, rare disease research
MDedge Family Medicine